Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.2M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
46.6K
-
Shares change
-
-89.6K
-
Total reported value, excl. options
-
$269K
-
Value change
-
-$426K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$5.81
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q4 2023
3 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q4 2023.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.6K shares
of 92.2M outstanding shares and own 0.05% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.07M shares), PFM Health Sciences, LP (6.48M shares), Avidity Partners Management LP (6.36M shares), STATE STREET CORP (5.12M shares), VANGUARD GROUP INC (3.96M shares), Point72 Asset Management, L.P. (3.52M shares), ALKEON CAPITAL MANAGEMENT LLC (3.11M shares), Paradigm Biocapital Advisors LP (2.92M shares), Elmwood Wealth Management, Inc. (2.36M shares), and Assenagon Asset Management S.A. (2.26M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.